Structure Therapeutics Inc. Stock Prediction and Forecast [GPCR]

AI-generated source summary

The analysis suggests a general sell signal due to the long-term average being above the short-term average. Downward corrections may find support at $18.08 and $18.60. A drop below these levels may trigger sell signals. However, a buy signal was issued from a pivot bottom on August 7, 2025, with the stock rising 24.20% since. Further rise is indicated until a new top pivot is established. MACD shows a buy signal and the volume is rising.The 3 months trend suggests a negative 26.21% change. 12 months projects change negative 55.47% a future price between $2.27 and $9.05. Resistance at $21.79 and support at $17.80. P/E Ratio: -5.96.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   16 Aug 2025, 03:11 UTC

   The analyst published the original source item.

2. First prediction resolved

   05 Sept 2025, 17:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   05 Sept 2025, 17:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 02:11 UTC

   Tahlil Plus began monitoring the extracted predictions.